Best treatments for tardive dyskinesia
4 products may treat tardive dyskinesia, spanning FDA drug classes such as vesicular monoamine transporter 2 inhibitor. The current highest-rated option is austedo xr. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 4 drugs we list for tardive dyskinesia, none are yet flagged as generics in our price data, spanning classes such as vesicular monoamine transporter 2 inhibitor. 1 of 4 carry a safety score of 54 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for tardive dyskinesia — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 54/100 | Prescription | Tablet | — | No data | — | View → | |
| 2 | Not yet rated | Prescription | Tablet | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Capsule | Vesicular Monoamine Transporter 2 Inhibitor | No data | — | View → | |
| 4 | Not yet rated | Prescription | Capsule | Vesicular Monoamine Transporter 2 Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: vesicular monoamine transporter 2 inhibitor
Full ranking · 4 treatments
austedo xr
Boxed warningPrescriptionFDA-sourced
Austedo XR (Deutetrabenazine) is a medication used to treat Tardive Dyskinesia, Chorea.
Price varies
austedo
Boxed warningPrescriptionFDA-sourced
Austedo (Deutetrabenazine) is a medication used to treat Tardive Dyskinesia, Chorea.
Price varies
ingrezza
Boxed warningPrescriptionFDA-sourced
Ingrezza (Valbenazine Tosylate) is a vesicular monoamine transporter 2 inhibitor used to treat Tardive Dyskinesia.
Price varies
ingrezza sprinkle
Boxed warningPrescriptionFDA-sourced
Ingrezza Sprinkle (Valbenazine Tosylate) is a vesicular monoamine transporter 2 inhibitor used to treat Tardive Dyskinesia.
Price varies
Frequently asked
- What treats tardive dyskinesia?
- Our catalog lists 4 products that may treat tardive dyskinesia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is austedo xr.
- What is the best-rated treatment for tardive dyskinesia?
- By our independent recall-safety rating — not an efficacy measure — austedo xr ranks highest among the products we list for tardive dyskinesia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat tardive dyskinesia?
- Treatments for tardive dyskinesia span FDA drug classes including vesicular monoamine transporter 2 inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status